Title:RETRACTED: Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate
VOLUME: 18 ISSUE: 14
Author(s):D.Y. Lu, T.R. Lu and B Xu
Affiliation:Department of Cancer Pharmacology, Shanghai University, Shanghai 200444, Department of Cancer Pharmacology, Shanghai University, Shanghai 200444, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203
Abstract:The article entitled “Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate”, by Lu
D.Y., Lu T.R., Xu B., Varki A., Huang M., Zhu H., Shen Y., Yarla N.S., has been retracted on the request of the co-authors Dr.
Ajit Varki, Ming Huang, Hong Zhu and Ying Shen available at: Anticancer Agents Med Chem. 2018; 18(14): 1952-1961.
http://www.eurekaselect.com/165282.
The Corresponding Author Dr. Da-Yong Lu has included the name of the co-author Dr. Ajit Varki, Dr. Nagendra Yarla, Ming
Huang, Hong Zhu and Ying Shen without their consent and the manuscript has been published in the journal Anti-Cancer Agents
in Medicinal Chemistry (ACAMC). Kindly see Bentham Science Policy on Article retraction at the link given below:
https://benthamscience.com/journals/anti-cancer-agents-in-medicinal-chemistry/editorial-policies/).
Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the
Copyright Letter or the Terms and Conditions. As such this article represents a severe abuse of the scientific publishing system.
Bentham Science Publishers takes a very strong view on this matter and apologizes to the readers of the journal for any
inconvenience this may cause.
